{"id":"W4417009738","doi":"10.1182/blood-2025-5352","title":"Fixed treatment duration mosunetuzumab continues to demonstrate clinically meaningful outcomes in patients with relapsed/refractory (R/R) follicular lymphoma (FL) after ≥2 prior therapies: 5-year follow-up of a pivotal Phase II study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Jewish General Hospital; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Follicular lymphoma; Adverse effect; Tolerability; Dosing; Incidence (geometry); Progressive disease; Phases of clinical research; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003902576,0.0005542299,0.001384251,0.0003377668,0.0004885785,0.00110606,0.0005959532,0.0008167618,0.001496694],"category_scores_gemma":[0.001899293,0.0002778828,0.001551084,0.000382907,0.000407774,0.0008500334,0.0003270444,0.001894471,0.0004825353],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007483573,"about_ca_system_score_gemma":0.0005347866,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006431984,"about_ca_topic_score_gemma":0.001239376,"domain_scores_codex":[0.9988801,0.0004217545,0.0001087146,0.0001948503,0.0001998304,0.0001947471],"domain_scores_gemma":[0.9976366,0.0004416963,0.0008702548,0.0002696178,0.0002462164,0.0005356077],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4206363,0.01765316,0.2188807,0.001050668,0.008223908,0.0006088339,0.0005216644,0.002542197,0.04913697,0.0002387586,0.005824021,0.2746827],"study_design_scores_gemma":[0.07103239,0.3138539,0.5895642,0.0001582964,0.005220632,0.001284872,0.0001780818,0.002222511,0.009079051,0.00025412,0.007065488,0.00008642788],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9912062,0.005801021,0.0003409049,0.0001871588,0.00003846038,0.0002737392,0.0007580813,0.00003676031,0.001357634],"genre_scores_gemma":[0.997485,0.0005058429,0.00021364,0.0002470426,0.00004877951,0.000114648,0.001074069,0.000006745764,0.0003043209],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003902576,"threshold_uncertainty_score":0.020639,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01385279050426851,"score_gpt":0.3059082007345945,"score_spread":0.2920554102303259,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}